Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis

J Infect Dis. 1994 Jun;169(6):1291-6. doi: 10.1093/infdis/169.6.1291.

Abstract

Toxin A produced by Clostridium difficile, the causative agent of pseudomembranous colitis and antibiotic-associated diarrhea, was shown to bind to synthetic oligosaccharide sequences attached to an inert support (SYNSORB). The oligosaccharide sequences that bind to toxin A were related to sequences previously identified as potential receptors for the toxin. Various SYNSORBs containing a variety of oligosaccharides were examined for their potential to neutralize toxin A activity from toxin-containing solutions as well as clinical stool samples from patients with either pseudomembranous colitis or antibiotic-associated diarrhea. The results from neutralization experiments suggest SYNSORB can effectively neutralize toxin A activity from stool samples and thus could serve as a potential therapy for C. difficile-associated diarrhea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Bacterial Toxins*
  • CHO Cells
  • Carbohydrate Sequence
  • Clostridioides difficile
  • Cricetinae
  • Diarrhea / chemically induced
  • Diarrhea / microbiology
  • Diarrhea / therapy*
  • Enterocolitis, Pseudomembranous / therapy*
  • Enterotoxins / antagonists & inhibitors*
  • Feces
  • Humans
  • Molecular Sequence Data
  • Oligosaccharides / pharmacology*
  • Oligosaccharides / therapeutic use
  • Rabbits
  • Silicon Dioxide

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Enterotoxins
  • Oligosaccharides
  • tcdA protein, Clostridium difficile
  • Silicon Dioxide